A Safety and Efficacy Dose-Ranging Study of GAP-486 in Subjects With Nonsustained Ventricular Tachycardia and Acute Ischemia
Latest Information Update: 06 May 2022
At a glance
- Drugs Rotigaptide (Primary)
- Indications Ventricular tachycardia
- Focus Therapeutic Use
- 07 Nov 2006 Status change
- 20 Nov 2005 New trial record.